CCT241736
Product Specifications
CAS Number
1402709-93-6
Target
FLT, Aurora Kinase
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis, Cell Cycle/Checkpoint, Chromatin/Epigenetic
Purity
0.9988
Bioactivity
CCT241736 is an orally bioavailable dual FLT3/Aurora kinase inhibitor that also inhibits clinically relevant FLT3-resistant mutants including FLT3-ITD and FLT3, CCT241736, an advanced analog of CCT137690, is a preclinical development candidate for the treatment of human malignancies, and in particular AML in adults and children.
Smiles
Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cnc2[nH]1
Molecular Formula
C22H23Cl2N7
Molecular Weight
456.37
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RG227058 10 µg
Mortality Factor 4 like 2 (MORF4L2) (NM_001142426) Human Tagged ORF Clone
Sign In for Pricing
View Details